A
ALX Oncology Holdings Inc. (ALXO)
NMS – Real Time Price. Currency in USD
2.00
+0.07 (3.37%)
Market open: Aug 12, 2026, 11:24 AM EDT
1.96
+0.03 (1.55%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
2.00
+0.07 (3.37%)
Market open: Aug 12, 2026, 11:24 AM EDT
1.96
+0.03 (1.55%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Cash reserves $0.0 barely cover the upcoming debt maturities $0.0
Total current assets $0.0 are just enough to cover Total current liabilities $0.0, indicating tight liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-64.1x) is dangerously low, suggesting debt repayment risks
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | N/A | 6.05 | 1.0 | |
| Quick ratio | N/A | 5.63 | 1.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | N/A | 1.04 | 1.0 | |
| Interest coverage | -64.11 | -16.91 | 1.0 | |
| Weighted average score | 1.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -1M | -836K | -872K | -706K | -454K |
| Operating Income | -127M | -170M | -142M | -101M | -83M |
| Net Income | -123M | -161M | -135M | -102M | -81M |
| EBITDA | -126M | -169M | -142M | -100M | -64M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 67.42 | 5.5 |
| Next quarter | N/A | 68.34 | 5.5 |
| Current year | N/A | 69.94 | 5.5 |
| Next year | N/A | 5.67 | 3.0 |
| Weighted average score | 4.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -0.24 | 23.53 | 1.74 | 6.0 |
| Y/Y | 999 | 30.74 | 73.47 | 24.37 | 10 |
| 3y average | 999 | 3.5 | 11.32 | -2.36 | 5.5 |
| 5y average | 779.2 | -23.97 | 2.52 | -23.66 | 4.0 |
| Weighted average score | 6.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |